Cocrystal Pharma (COCP) Capital Expenditures Growth (1y) (2011 - 2024)
Cocrystal Pharma (COCP) Capital Expenditures Growth (1y) (2011 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -82.22% |
| Dec 31, 2023 | 391.67% |
| Dec 31, 2022 | 50.00% |
| Dec 31, 2021 | 700.00% |
| Sep 30, 2021 | -78.95% |
| Jun 30, 2021 | -88.19% |
| Mar 31, 2021 | -73.12% |
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | -83.48% |
| Jun 30, 2020 | 3,075.00% |
| Mar 31, 2020 | 272.00% |
| Dec 31, 2019 | -93.33% |
| Sep 30, 2019 | 1,337.50% |
| Mar 31, 2019 | 400.00% |
| Mar 31, 2018 | -84.85% |
| Jun 30, 2017 | -61.11% |
| Mar 31, 2017 | 83.33% |
| Dec 31, 2016 | -98.36% |
| Sep 30, 2013 | -4.31% |
| Jun 30, 2013 | -84.59% |